Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Plazomicin Sulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17,469Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 1380078-95-4, Plazomicin sulfate [usan], Plazomicin sulfate (usan), (2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-4-[[(2s,3r)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2h-pyran-2-yl]oxy]-2-[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric acid, Plazomicin hemipentasulfate, (s)-4-amino-n-((1r,2s,3s,4r,5s)-5-amino-4-(((2s,3r)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2h-pyran-2-yl)oxy)-2-(((2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2h-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide sulfate(1:x)
    Molecular Formula
    C25H50N6O14S
    Molecular Weight
    690.8  g/mol
    InChI Key
    SFTBRKHJMASSAP-BGJNVEJLSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric acid
    2.1.2 InChI
    InChI=1S/C25H48N6O10.H2O4S/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32;1-5(2,3)4/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36);(H2,1,2,3,4)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+;/m1./s1
    2.1.3 InChI Key
    SFTBRKHJMASSAP-BGJNVEJLSA-N
    2.1.4 Canonical SMILES
    CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O.OS(=O)(=O)O
    2.1.5 Isomeric SMILES
    C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CNCCO)N)N)NC(=O)[C@H](CCN)O)O.OS(=O)(=O)O
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. 1380078-95-4

    2. Plazomicin Sulfate [usan]

    3. Plazomicin Sulfate (usan)

    4. (2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-4-[[(2s,3r)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2h-pyran-2-yl]oxy]-2-[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric Acid

    5. Plazomicin Hemipentasulfate

    6. (s)-4-amino-n-((1r,2s,3s,4r,5s)-5-amino-4-(((2s,3r)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2h-pyran-2-yl)oxy)-2-(((2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2h-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide Sulfate(1:x)

    7. A78l6mt746

    8. Unii-a78l6mt746

    9. Zemdri (tn)

    10. Chembl2364623

    11. Dtxsid60160452

    12. D10655

    13. Q27273718

    14. (2s)-4-amino-n-((1r,2s,3s,4r,5s)-5-amino-4-((2-amino-2,3,4,6-tetradeoxy-6-((2-hydroxyethyl)amino)-alpha-d-glycero-hex-4-enopyranosyl)oxy)-2-((3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide Sulfate

    15. D-streptamine, O-2-amino-2,3,4,6-tetradeoxy-6-((2-hydroxyethyl)amino)-alpha-d-glycero-hex-4-enopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6))-n(sup 1)-((2s)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, Sulfate (1:?)

    2.3 Create Date
    2013-06-10
    3 Chemical and Physical Properties
    Molecular Weight 690.8 g/mol
    Molecular Formula C25H50N6O14S
    Hydrogen Bond Donor Count13
    Hydrogen Bond Acceptor Count19
    Rotatable Bond Count13
    Exact Mass690.31057146 g/mol
    Monoisotopic Mass690.31057146 g/mol
    Topological Polar Surface Area352 Ų
    Heavy Atom Count46
    Formal Charge0
    Complexity954
    Isotope Atom Count0
    Defined Atom Stereocenter Count12
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2